Evidence map›Paper›PMID 33449222›Full record

ArticleAntonie van Leeuwenhoek2021

Genomic insight into a novel actinobacterium, Actinomadura rubrisoli sp. nov., reveals high potential for bioactive metabolites.

Hilal Ay

Abstract read
PubMed Publisher
In one paragraph

Article in Antonie van Leeuwenhoek, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hilal AyDepartment of Molecular Biology and Genetics, Faculty of Science and Arts, Ondokuz Mayis University, Samsun, Turkey. hilal.ay@omu.edu.tr.ORCID http://orcid.org/0000-0002-8735-4703

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Isolation of novel actinobacteria from unexplored habitats as potential sources of novel drug leads has utmost importance. During the course of screening arid soil samples for novel actinobacteria, strain H3C3

Indexed as

ActinobacteriaActinomaduraBacterial Typing TechniquesCell WallDNA, BacterialFatty AcidsGenomicsNucleic Acid HybridizationPhylogenyRNA, Ribosomal, 16SSequence Analysis, DNASoil MicrobiologyVitamin K 2DNA, BacterialFatty AcidsRNA, Ribosomal, 16SVitamin K 2ActinobacteriaAntimicrobial resistance genesBiosynthetic gene clustersPhylogenomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.